Fort Washington Investment Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-681,319
Closed -$12.6M 498
2019
Q3
$12.6M Buy
681,319
+30,000
+5% +$587K 0.14% 137
2019
Q2
$12.8M Buy
651,319
+5,000
+0.8% +$102K 0.14% 154
2019
Q1
$14.8M Sell
646,319
-155,000
-19% -$3.37M 0.17% 120
2018
Q4
$16.1M Buy
801,319
+62,840
+9% +$1.3M 0.2% 128
2018
Q3
$16.1M Sell
738,479
-65,000
-8% -$1.44M 0.16% 162
2018
Q2
$17.9M Sell
803,479
-225,000
-22% -$4.6M 0.18% 120
2018
Q1
$17.7M Buy
1,028,479
+127,000
+14% +$2.12M 0.18% 113
2017
Q4
$15M Buy
+901,479
New +$15.4M 0.15% 170

Other funds holding ANGO

Fort Washington Investment Advisors's ANGO Position: Q4 2019 in Review

Fort Washington Investment Advisors sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 681,319 shares — an estimated $12.6M sold.

Fort Washington Investment Advisors first reported a position in ANGO in Q4 2017 and held it in 8 quarters. The position peaked at $17.9M in Q2 2018. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

  • Fort Washington Investment Advisors reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 681,319 AngioDynamics shares in Q4 2019, an estimated $12.6M.
  • Fort Washington Investment Advisors first reported a position in AngioDynamics in Q4 2017 and held it in 8 quarters.
  • Fort Washington Investment Advisors's AngioDynamics position peaked at $17.9M in Q2 2018.
  • 157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Fort Washington Investment Advisors's 13F filing for Q4 2019, filed 3 Feb 2020.